glp 1 agonist retatrutide Medscape | The investigational triple GLP-1/GIP/glucagon receptor produced significant weight loss and A1c reduction in people Retatrutide for weight loss: Study

Survodutide: Dual GLP-1R/GCGR agonist with glucagon-favoring activity ratio (~4-5x GCGR vs GLP-1R)

& Afshari, A

The technology commercialization and patent application is led by Baylor Licensing Group, the technology transfer office at Baylor College of Medicine, with the mission to maximize the impact of research at Baylor College of Medicine through commercial relationships that lead to agreements to support the development of new products and services that benefit patients and the public.

The type you choose can affect how easy it is to consume, how well it fits into your routine, and how consistently you meet your daily protein needs